Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia

详细信息    查看全文

• 作者：Samer A. Srour¹ ; ² ; Dená ; i R. Milton³ ; Asad Bashey⁴ ; Amado Karduss-Urueta⁵ ; Monzr M. Al Malki⁶ ; Rizwan Romee⁷ ; Scott Solomon³ ; Auayporn Nademanee⁶ ; Stacey Brown⁴ ; Michael Slade⁷ ; Rosendo Perez⁵ ; Gabriela Rondon¹ ; Stephan J. Forman⁶ ; Richard E. Champlin¹ ; Partow Kebriaei¹ ; Stefan O. Ciurea¹ ; ^{sciurea@mdanderson.org}
• 关键词：Acute lymphoblastic leukemia ; Haploidentical transplantation
• 刊名：Biology of Blood and Marrow Transplantation
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：23
• 期：2
• 页码：318-324
• 全文大小：614 K
• 卷排序：23

文摘

Haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for prevention of graft-versus-host disease is feasible for patients with acute lymphoblastic leukemia Patients in first complete remission have very good long-term survival Haploidentical donors provide a very suitable alternative to HLA-matched transplantation